Well I'm arguing the market has spoken and they believe this will be a winner. I commented here many times during Friday trading that the US investors will sort out the artificial speed hump we saw on the ASX because of dumb traders. And that's what has happened.
The monster volumes are telling me this company is undergoing its most significant re-rating in its history.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-505
-
- There are more pages in this discussion • 343 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |